| 000 | 01491 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513183556.0 | ||
| 264 | 0 | _c19990917 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0885-3185 | ||
| 024 | 7 |
_a10.1002/1531-8257(199905)14:3<520::aid-mds1026>3.0.co;2-v _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavis, L E | |
| 245 | 0 | 0 |
_aParkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _cMay 1999 |
||
| 300 |
_a520-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Edema _xchemically induced |
| 650 | 0 | 4 |
_aBromocriptine _xtherapeutic use |
| 650 | 0 | 4 |
_aCarbidopa _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethanol _xpoisoning |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aPutamen _xdiagnostic imaging |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 700 | 1 | _aAdair, J C | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 14 _gno. 3 _gp. 520-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1531-8257(199905)14:3<520::aid-mds1026>3.0.co;2-v _zAvailable from publisher's website |
| 999 |
_c10307153 _d10307153 |
||